These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32571361)

  • 1. Modelling HIV disease process and progression in seroconversion among South Africa women: using transition-specific parametric multi-state model.
    Dessie ZG; Zewotir T; Mwambi H; North D
    Theor Biol Med Model; 2020 Jun; 17(1):10. PubMed ID: 32571361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling immune deterioration, immune recovery and state-specific duration of HIV-infected women with viral load adjustment: using parametric multistate model.
    Dessie ZG; Zewotir T; Mwambi H; North D
    BMC Public Health; 2020 Mar; 20(1):416. PubMed ID: 32228523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel ordinal model for CD4 count trends in seroconversion among South Africa women.
    Dessie ZG; Zewotir T; Mwambi H; North D
    BMC Infect Dis; 2020 Jun; 20(1):447. PubMed ID: 32576220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral naive cohort: using a joint linear mixed and multistate Markov model.
    Dessie ZG; Zewotir T; Mwambi H; North D
    BMC Infect Dis; 2020 Mar; 20(1):246. PubMed ID: 32216755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate multilevel modeling of quality of life dynamics of HIV infected patients.
    Dessie ZG; Zewotir T; Mwambi H; North D
    Health Qual Life Outcomes; 2020 Mar; 18(1):80. PubMed ID: 32209095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study.
    Shoko C; Chikobvu D; Bessong PO
    Pak J Biol Sci; 2020 Mar; 23(4):542-551. PubMed ID: 32363840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study.
    Wang L; Krebs E; Min JE; Mathews WC; Nijhawan A; Somboonwit C; Aberg JA; Moore RD; Gebo KA; Nosyk B;
    Lancet HIV; 2019 Aug; 6(8):e531-e539. PubMed ID: 31303557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa.
    Shoko C; Chikobvu D
    Theor Biol Med Model; 2018 Jan; 15(1):3. PubMed ID: 29343268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV-1 infection: results from a longitudinal study in the French ANRS Primo cohort.
    Novelli S; Delobel P; Bouchaud O; Avettand-Fenoel V; Fialaire P; Cabié A; Souala F; Raffi F; Catalan P; Weiss L; Meyer L; Goujard C
    J Int AIDS Soc; 2020 Apr; 23(4):e25485. PubMed ID: 32333726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markov modelling of viral load adjusting for CD4 orthogonal variable and multivariate conditional autoregressive mapping of the HIV immunological outcomes among ART patients in Zimbabwe.
    Matsena Zingoni Z; Chirwa TF; Todd J; Musenge E
    Theor Biol Med Model; 2021 Aug; 18(1):16. PubMed ID: 34419087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive quantile mixed effects modelling with application to longitudinal CD4 count data.
    Yirga AA; Melesse SF; Mwambi HG; Ayele DG
    Sci Rep; 2021 Sep; 11(1):17945. PubMed ID: 34504147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.
    Riddler SA; Husnik M; Ramjee G; Premrajh A; Tutshana BO; Pather A; Siva S; Jeenarain N; Nair G; Selepe P; Kabwigu S; Palanee-Phillips T; Panchia R; Mhlanga F; Levy L; Livant E; Patterson K; Elharrar V; Balkus J
    PLoS One; 2017; 12(6):e0178594. PubMed ID: 28658251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.
    Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania.
    Mosha F; Muchunguzi V; Matee M; Sangeda RZ; Vercauteren J; Nsubuga P; Lyamuya E; Vandamme AM
    BMC Public Health; 2013 Jan; 13():38. PubMed ID: 23320567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid disease progression in HIV-1 subtype C-infected South African women.
    Mlisana K; Werner L; Garrett NJ; McKinnon LR; van Loggerenberg F; Passmore JA; Gray CM; Morris L; Williamson C; Abdool Karim SS;
    Clin Infect Dis; 2014 Nov; 59(9):1322-31. PubMed ID: 25038116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
    Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
    Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
    Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
    J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.